If an oncologist was apprehensive about Steven Edwards getting a second opinion, that might not be the right doctor for him, the kidney cancer survivor said.
After being diagnosed with kidney cancer — which was a possible result of exposure to the 9/11 terrorist attacks in New York City – Steven Edwards realized that he had to be his own advocate. Pivotal to his advocacy was asking questions and getting as many professional opinions as possible.
“I probably would consider whether it was the right doctor for me in the first place if a doctor was upset about getting a second opinion, because it’s all about gathering education and becoming educated yourself,” Edwards said in an interview with CURE®.
Edwards went through multiple different treatments, including the participation on a clinical trial, and continues to push for better outcomes for himself and other survivors through being an advocate for the Kidney Cancer Association and KidneyCAN.
Through cancer setbacks like a diagnosis of metastatic disease in 2017, classifying Edwards’ disease as stage 4, he continues to seek information in this rapidly changing field. After all, “There’s only way to go, and that’s forward,” Edwards said.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Welireg Made a von Hippel-Lindau Survivor Feel Like a 'Medical Miracle'
December 15th 2022When Sean Korbitz was a 20-year-old college student, his life trajectory changed with a rare cancer diagnosis, resulting in the removal of 40 tumors; fifteen years later, a new drug made him feel like a “medical miracle.”
Listen
Zanzalintinib Is Promising in Clear-Cell Advanced Renal Cell Carcinoma
November 14th 2023Patients with advanced clear cell renal cell carcinoma treated with zanzalintinib had experienced promising antitumor activity with manageable toxicity regardless of prior treatment with cabozantinib.
Read More
Genetic Mutations May Explain Heart Events in Some Patients With Kidney Cancer
November 13th 2023Although research has delved into the potential link between clonal hematopoiesis and heart-related events such as heart attacks and strokes in patients with kidney cancer, more research is needed to further understand this association.
Read More